![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19. |
Liver Cirrhosis |
Free Subscription
|
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Cirrhosis is free of charge.
Associations between non-insulin-based insulin resistance surrogate markers and
liver-related outcomes in metabolic dysfunction-associated steatotic liver
disease: a nationwide cohort study in South Korea.
BMC Gastroenterol. 2025;25:274.
PubMed
Abstract available
The association between modified cardiometabolic index with non-alcoholic fatty
liver disease and liver fibrosis: a cross-sectional study.
BMC Gastroenterol. 2025;25:265.
PubMed
Abstract available
Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver
fibrosis.
BMC Gastroenterol. 2025;25:252.
PubMed
Abstract available
Cirrhosis and age are key determinants of HCC risk in individuals with primary
sclerosing cholangitis: A multicenter longitudinal cohort study.
Hepatology. 2025 Apr 16. doi: 10.1097/HEP.0000000000001351.
PubMed
Abstract available
Incidence of liver complications with hemochromatosis associated HFE p.C282Y
homozygosity: The role of central adiposity.
Hepatology. 2024 Aug 23. doi: 10.1097/HEP.0000000000001056.
PubMed
Abstract available
The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with
Undetectable HBV-DNA under NA Therapy: A Multicenter Study.
Intern Med. 2025;64:1133-1141.
PubMed
Abstract available
Survey on Awareness and Implementation Rate of Ultrasound Elastography and
Attenuation Imaging.
Intern Med. 2025;64:1143-1149.
PubMed
Abstract available
Advancing our understanding of recompensated cirrhosis - the new "holy grail" of
decompensated cirrhosis.
J Hepatol. 2025 Apr 16:S0168-8278(25)00241-7. doi: 10.1016/j.jhep.2025.
PubMed
Validation and expansion of Baveno VII recompensation criteria in patients with
cirrhosis and curable liver disease.
J Hepatol. 2025 Apr 12:S0168-8278(25)00245-4. doi: 10.1016/j.jhep.2025.
PubMed
Abstract available
Carvedilol is Associated with Lower Risk of Hepatic Decompensation Compared to
Other Non-Selective Beta-Blockers in Cirrhosis.
J Hepatol. 2025 Apr 11:S0168-8278(25)00232-6. doi: 10.1016/j.jhep.2025.
PubMed
A Rare Cause of Lipid Metabolism Disorder and Cirrhosis in an Adult.
J Hepatol. 2025 Apr 9:S0168-8278(25)00227-2. doi: 10.1016/j.jhep.2025.
PubMed
A new generation of non-invasive tests of liver fibrosis with improved accuracy
in MASLD.
J Hepatol. 2025;82:794-804.
PubMed
Abstract available
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in
MASH.
J Hepatol. 2025;82:898-908.
PubMed
Abstract available
Multi-Modal Analysis of human Hepatic Stellate Cells identifies novel therapeutic
targets for Metabolic Dysfunction-Associated Steatotic Liver Disease.
J Hepatol. 2024 Nov 8:S0168-8278(24)02667-9. doi: 10.1016/j.jhep.2024.
PubMed
Abstract available
Thank you for your interest in scientific medicine.